Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia a and von Willebrand's disease
Takase, T.; Nishino, M.; Yasui, M.; Shima, M.; Yoshikawa, N.; Fukui, H.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 48(7): 1571-1578
1985
ISSN/ISBN: 0001-5806 PMID: 3937410 Document Number: 265114
Document emailed within 1 workday
Related Documents
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S. 1985: Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP Ugeskrift for Laeger 147(45): 3592-3594
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Bolland, J.; Lambotte, C. 1978: Factor VIIi in hemophilia and von Willebrand's disease Revue Medicale de Liege 33(8): 284-295
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Vicente, V.; Alberca, I.; Moraleda, J.M.; López Borrasca, A. 1983: DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand Sangre 28(4): 531-532
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172
Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Canales Albendea, M.A.; Villar Camacho, A.; Chamarro Merino, G.; Magallón Martínez, M. 1998: Ultrapure factor VIIi concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients Sangre 43(1): 93-94
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Reuter, H.; Tilsner, V. 1978: Two-dimensional immunoelectrophoresis for the determination of factor-VIII-associated protein. Variation in the von Willebrand-Jürgens syndrome Die Medizinische Welt 29(25): 1053-1055
Sultan, Y.; Loyer, F.; Venot, A. 1992: Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease Nouvelle Revue Francaise D'hematologie 34(1): 55-60
Ablin, R.J. 1987: Improved enzyme immunoassay for factor VIII-related antigen (von Willebrand factor antigen) Clinical Chemistry 33(10): 1935-1936
Orthner, C.L. 1984: Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography Journal of Laboratory and Clinical Medicine 104(5): 816-828